drugset / Trial / NCT00032110
Erlotinib in Treating Patients With Recurrent or Metastatic Colorectal Cancer
NaSingle-groupOpen-labelTreatment
Summary
Biological therapies such as erlotinib may interfere with the growth of tumor cells and slow the growth of the tumor. Phase II trial to study the effectiveness of erlotinib in treating patients who have recurrent or metastatic colorectal cancer.
Timeline
- Start
- 2002-01
- Primary completion
- 2007-05
- Completion
- 2007-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Erlotinib | Small molecule | — | Oral |